Mesa Laboratories (MLAB) Current Deferred Revenue (2013 - 2026)

Mesa Laboratories has reported Current Deferred Revenue for 13 years, with the latest figure at $14.6 million in Q4 2025.

• Quarterly Current Deferred Revenue fell 0.96% year-over-year to $14.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.6 million (down 0.96% YoY) and the FY2025 annual result came in at $14.8 million, down 4.36% from the prior year.
• Current Deferred Revenue climbed to $14.6 million in Q4 2025 per MLAB's latest filing, from $14.3 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $16.3 million in Q3 2022 and troughed at $8.8 million in Q1 2021.
• A 5-year average of $14.2 million and a median of $14.7 million in 2024 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue surged 71.69% in 2022, then slipped 11.56% in 2023.
• Over 5 years, Current Deferred Revenue stood at $13.8 million in 2021, then advanced by 17.56% to $16.2 million in 2022, then fell by 11.56% to $14.4 million in 2023, then climbed by 2.46% to $14.7 million in 2024, then retreated by 0.96% to $14.6 million in 2025.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $14.6 million, $14.3 million, and $15.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.